Cargando…
Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction
There is a paucity of data characterizing right ventricular performance in heart failure with preserved ejection fraction (HFpEF) using the gold standard of cardiovascular magnetic resonance imaging (CMR). We aimed to assess the proportion of right ventricular systolic dysfunction (RVD) in HFpEF and...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878207/ https://www.ncbi.nlm.nih.gov/pubmed/32737707 http://dx.doi.org/10.1007/s10554-020-01953-y |
_version_ | 1783650309437915136 |
---|---|
author | Kanagala, Prathap Arnold, Jayanth R. Singh, Anvesha Khan, Jamal N. Gulsin, Gaurav S. Gupta, Pankaj Squire, Iain B. Ng, Leong L. McCann, Gerry P. |
author_facet | Kanagala, Prathap Arnold, Jayanth R. Singh, Anvesha Khan, Jamal N. Gulsin, Gaurav S. Gupta, Pankaj Squire, Iain B. Ng, Leong L. McCann, Gerry P. |
author_sort | Kanagala, Prathap |
collection | PubMed |
description | There is a paucity of data characterizing right ventricular performance in heart failure with preserved ejection fraction (HFpEF) using the gold standard of cardiovascular magnetic resonance imaging (CMR). We aimed to assess the proportion of right ventricular systolic dysfunction (RVD) in HFpEF and the relation to clinical outcomes. As part of a single-centre, prospective, observational study, 183 subjects (135 HFpEF, and 48 age- and sex-matched controls) underwent extensive characterization with CMR. transthoracic echocardiography, blood sampling and six-minute walk testing. Patients were followed for the composite endpoint of death or HF hospitalization. RVD (defined as right ventricular ejection fraction < 47%) controls was present in 19% of HFpEF. Patients with RVD presented more frequently with lower systolic blood pressure, atrial fibrillation, radiographic evidence of pulmonary congestion and raised cardiothoracic ratio and larger right ventricular volumes. During median follow-up of 1429 days, 47% (n = 64) of HFpEF subjects experienced the composite endpoint of death (n = 22) or HF hospitalization (n = 42). RVD was associated with an increased risk of composite events (Log-Rank p = 0.001). In multivariable Cox regression analysis, RVD was an independent predictor of adverse outcomes (adjusted Hazard Ratio [HR] 3.946, 95% CI 1.878–8.290, p = 0.0001) along with indexed extracellular volume (HR 1.742, CI 1.176–2.579, p = 0.006) and E/E’ (HR 1.745, CI 1.230–2.477, p = 0.002). RVD as assessed by CMR is prevalent in nearly one-fifth of HFpEF patients and is independently associated with death and/or hospitalization with HF. The trial was registered retrospectively on ClinicalTrials.gov (Identifier: NCT03050593). The date of registration was February 06, 2017. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10554-020-01953-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7878207 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-78782072021-02-22 Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction Kanagala, Prathap Arnold, Jayanth R. Singh, Anvesha Khan, Jamal N. Gulsin, Gaurav S. Gupta, Pankaj Squire, Iain B. Ng, Leong L. McCann, Gerry P. Int J Cardiovasc Imaging Original Paper There is a paucity of data characterizing right ventricular performance in heart failure with preserved ejection fraction (HFpEF) using the gold standard of cardiovascular magnetic resonance imaging (CMR). We aimed to assess the proportion of right ventricular systolic dysfunction (RVD) in HFpEF and the relation to clinical outcomes. As part of a single-centre, prospective, observational study, 183 subjects (135 HFpEF, and 48 age- and sex-matched controls) underwent extensive characterization with CMR. transthoracic echocardiography, blood sampling and six-minute walk testing. Patients were followed for the composite endpoint of death or HF hospitalization. RVD (defined as right ventricular ejection fraction < 47%) controls was present in 19% of HFpEF. Patients with RVD presented more frequently with lower systolic blood pressure, atrial fibrillation, radiographic evidence of pulmonary congestion and raised cardiothoracic ratio and larger right ventricular volumes. During median follow-up of 1429 days, 47% (n = 64) of HFpEF subjects experienced the composite endpoint of death (n = 22) or HF hospitalization (n = 42). RVD was associated with an increased risk of composite events (Log-Rank p = 0.001). In multivariable Cox regression analysis, RVD was an independent predictor of adverse outcomes (adjusted Hazard Ratio [HR] 3.946, 95% CI 1.878–8.290, p = 0.0001) along with indexed extracellular volume (HR 1.742, CI 1.176–2.579, p = 0.006) and E/E’ (HR 1.745, CI 1.230–2.477, p = 0.002). RVD as assessed by CMR is prevalent in nearly one-fifth of HFpEF patients and is independently associated with death and/or hospitalization with HF. The trial was registered retrospectively on ClinicalTrials.gov (Identifier: NCT03050593). The date of registration was February 06, 2017. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10554-020-01953-y) contains supplementary material, which is available to authorized users. Springer Netherlands 2020-07-31 2021 /pmc/articles/PMC7878207/ /pubmed/32737707 http://dx.doi.org/10.1007/s10554-020-01953-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Paper Kanagala, Prathap Arnold, Jayanth R. Singh, Anvesha Khan, Jamal N. Gulsin, Gaurav S. Gupta, Pankaj Squire, Iain B. Ng, Leong L. McCann, Gerry P. Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction |
title | Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction |
title_full | Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction |
title_fullStr | Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction |
title_full_unstemmed | Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction |
title_short | Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction |
title_sort | prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878207/ https://www.ncbi.nlm.nih.gov/pubmed/32737707 http://dx.doi.org/10.1007/s10554-020-01953-y |
work_keys_str_mv | AT kanagalaprathap prevalenceofrightventriculardysfunctionandprognosticsignificanceinheartfailurewithpreservedejectionfraction AT arnoldjayanthr prevalenceofrightventriculardysfunctionandprognosticsignificanceinheartfailurewithpreservedejectionfraction AT singhanvesha prevalenceofrightventriculardysfunctionandprognosticsignificanceinheartfailurewithpreservedejectionfraction AT khanjamaln prevalenceofrightventriculardysfunctionandprognosticsignificanceinheartfailurewithpreservedejectionfraction AT gulsingauravs prevalenceofrightventriculardysfunctionandprognosticsignificanceinheartfailurewithpreservedejectionfraction AT guptapankaj prevalenceofrightventriculardysfunctionandprognosticsignificanceinheartfailurewithpreservedejectionfraction AT squireiainb prevalenceofrightventriculardysfunctionandprognosticsignificanceinheartfailurewithpreservedejectionfraction AT ngleongl prevalenceofrightventriculardysfunctionandprognosticsignificanceinheartfailurewithpreservedejectionfraction AT mccanngerryp prevalenceofrightventriculardysfunctionandprognosticsignificanceinheartfailurewithpreservedejectionfraction |